Trial intelligence / Profile preview

Clozapine versus risperidone for cannabis craving-related brain activity in schizophrenia

2008-003623-23Phase 3Active

Sponsor
Amsterdam University Medical Center
Start
Aug 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in schizophrenia and cannabis use disorder (CUD) comparing Clozapine with Risperidone (2 arms). Primary endpoints: Craving-related functional brain activity and Subjective cannabis craving. Started Aug 2008; status: active.

02

Drugs

clozapinerisperidone
03

Conditions

schizophreniacannabis use disorder (CUD)

Beyond the preview

Go deeper on 2008-003623-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003623-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call